Nectar Lifesciences has received US Food and Drug Administration's approval for its active pharmaceutical ingredients manufacturing plan. Nectar Lifesciences Ltd. announced that it has received US Food and Drug Administration's (USFDA) approval for its Active Pharmaceutical Ingredients (APIs) manufacturing plant Unit-II in Dera Bassi, Punjab. Followed by the recent audit of USFDA in June 2011 for its Drug Master File - Cefuroxime Axetil, NecLife received the confirmation of approval on September 7, 2011.
An essential component of our corporate social responsibility is to care for the community. NLL endeavor to make a positive contribution to the underprivileged communities by supporting a wide range of socio-economic, educational and health initiatives.
NLL strongly belives in Nurturing & Enriching its Human capital & workforce in an efforts to make life worth living for workmen. These efforts has delivered to win over employee’s loyalty, satisfactory, productivity and increase their morale.
Nectar Lifesciences Limited opened a charitable, registered vocational Institute on 18th May 2010 called Nectar Polytechnic for women (A unit of Nectar Lifesciences Charitable Foundation) under the Act XXI of 1860.